Waters Corporation
Financials
Valuation Metrics
Waters Corporation's Market Cap is $45.43B. At end of 2025 it was $22.62B. Ranked #337 of 3,118 in US market (top 11%), #242 of 1,644 on NYSE (top 15%), #22 of 203 in Health Care Equipment & Services (top 11%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $45.43B | US#337/3,118 Sec#22/203 |
| Revenue | $4.64B | US#928/3,118 Sec#53/203 |
| Net Income | $166M | US#1,384/3,118 Sec#69/203 |
| Total Assets | $24.75B | US#541/3,118 Sec#25/203 |
| Net Assets | $15.20B | US#293/3,118 Sec#17/203 |
| Employees | 7,900 | US#980/3,118 Sec#74/203 |
| Value | ||
| P/E | 273.46x | US#2,185/3,118 Sec#117/203 |
| P/B | 2.99x | US#1,772/3,118 Sec#91/203 |
| P/S | 9.78x | US#2,695/3,118 Sec#181/203 |
| EV/EBITDA | 55.98x | US#2,373/3,118 Sec#129/203 |
| FCF Yield | 0.88% | US#2,174/3,118 Sec#133/203 |
| Profitability | ||
| ROE | 1.09% | US#2,080/3,118 Sec#113/203 |
| ROA | 0.67% | US#2,085/3,118 Sec#119/203 |
| Op. Margin | 7.96% | US#1,737/3,118 Sec#94/203 |
| Revenue Growth | 52.47% | US#214/3,118 Sec#9/203 |
| Earnings Growth | -74.88% | US#1,794/3,118 Sec#96/203 |
| Financial Health | ||
| Debt Ratio | 62.89% | US#691/3,118 Sec#76/203 |
| Total Debt | $5.25B | US#650/3,118 Sec#33/203 |
| FCF | $398M | US#993/3,118 Sec#58/203 |
| Cash | $539M | US#1,024/3,118 Sec#56/203 |
| Current Ratio | 1.86x | US#1,315/3,118 Sec#115/203 |
| Net Debt/EBITDA | 5.26x | US#2,053/3,118 Sec#131/203 |
| Performance | ||
| 1Y Return | 34.94% | US#759/3,118 Sec#69/203 |
| 1M Return | 5.31% | US#1,217/3,118 Sec#104/203 |
| From 52W High | -4.06% | US#327/3,118 Sec#29/203 |
| 1Y MDD | -31.32% | US#1,400/3,118 Sec#72/203 |
| Trading | ||
| Volume | 1,100,017 shares | US#1,413/3,118 Sec#86/203 |
| Trading Value | $514M | US#228/3,118 Sec#19/203 |
| Per Share | ||
| EPS | $1.69 | US#1,441/3,118 Sec#74/203 |
| BPS | $154.76 | US#38/3,118 Sec#5/203 |
Company Info
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.